EUVIMEDEUVIMED entdecken
Systematische Übersicht

Patients Undergoing Primary Hip Arthroscopy Report Favorable Outcomes at Minimum 10 Year Follow‐Up: A Systematic Review

Michael S Lee, David Nam-Woo Kim, Jay Moran, Stephen M Gillinov, Ronak J Mahatme, Peter F Monahan, Wasif Islam, William M Mclaughlin, Nathan L Grimm, Andrew E Jimenez

Arthroscopy · 2023-02 · 39 (2) · 459-475

DOI: 10.1016/j.arthro.2022.10.040 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Arthroscopy, online erschienen am 02.11.2022. Verfasst von Michael S Lee und 9 weiteren Autor:innen. Beteiligte Einrichtung: Medical College of Wisconsin, Milwaukee, Wisconsin. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Femoracetabular Impingement. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 33 Literaturangaben. Gefördert von: Arthrex.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

(1) To evaluate minimum 10‐year PROs (patient‐reported outcomes) and survivorship after primary hip arthroscopy and (2) to identify predictors of failure for secondary arthroscopy and conversion to total hip arthroplasty (THA).

Methods

A systematic review of the literature was conducted with the following key words: “hip arthroscopy,” “long‐term,” “outcomes,” “ten‐year,” “survivorship,” “10‐year,” “15‐year,” “fifteen‐year,” 20‐year,” “twenty‐year,” and “femoroacetabular impingement” in PubMed and Embase in March 2022 using the Preferred Reporting Items for Systematic Reviews and Meta‐analyses guidelines. Level I to Level IV evidence was included and reported on minimum 10‐year outcomes or greater after primary hip arthroscopy. Long‐term studies were defined as minimum 10‐year follow‐up in accordance with established standards in the literature. Case reports, review articles, technique articles, and opinion articles were excluded. Articles not in English were excluded. Title, author, publication date, study design, demographic, number of hips, follow‐up time, study period, indications for hip arthroscopy, PROs, predictors of failure for THA, and rates of secondary surgeries were recorded. Survivorship was defined as a nonconversion to THA. P < .05 was defined as statistical significance.

Results

Twelve studies met the inclusion criteria. In total, 4 studies were Level III, and 8 studies were Level IV. A total of 1,344 hips were included, and follow‐up ranged from 10 to 20 years. Femoroacetabular impingement syndrome was the most common indication for hip arthroscopy. Ten of the 12 studies reported on PROs, and 8 studies reported significant improvement after hip arthroscopy at long‐term follow‐up. The remaining 2 studies reported favorable outcomes that satisfied clinical benefit thresholds at minimum 10‐year follow‐up. Five studies reported clinical benefit where each patient cohort achieved 80% minimal clinically important difference and 75% patient acceptable symptomatic state for at least one PRO. Rates of secondary arthroscopy ranged from 4.5% to 24%, and rates of conversion to THA varied from 0% to 44.1%. Older age and chondral damage were the most commonly cited predictors for conversion to THA.

Conclusions

At long‐term follow‐up, patients who underwent primary hip arthroscopy demonstrated favorable outcomes and variable rates of secondary surgeries. Patients undergoing hip arthroscopy within the last 20 years with Tönnis grade

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Arthroplasty, Replacement, HipFemoracetabular ImpingementHumansHip JointTreatment OutcomeArthroscopyPatient SatisfactionPatient Reported Outcome MeasuresFollow-Up StudiesRetrospective Studies

Autor:innen und Institutionen

  • Medical College of Wisconsin, Milwaukee, Wisconsin.
  • Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, Connecticut.
  • University of Connecticut School of Medicine, Farmington, Connecticut.
  • Penn State College of Medicine, Hershey, Pennsylvania.
  • Idaho Sports Medicine Institute, Boise, Idaho U.S.A.
  • Department of Orthopaedics and Rehabilitation, Yale School of Medicine, New Haven, Connecticut. Electronic address: andrew.jimenez@yale.edu.

Förderung

  • Arthrex

Zitieren

APA

Lee, M. S., Nam-Woo Kim, D., Moran, J., Gillinov, S. M., Mahatme, R. J., Monahan, P. F., Islam, W., Mclaughlin, W. M., Grimm, N. L., & Jimenez, A. E. (2023). Patients Undergoing Primary Hip Arthroscopy Report Favorable Outcomes at Minimum 10 Year Follow‐Up: A Systematic Review. Arthroscopy, 39(2), 459-475. https://doi.org/10.1016/j.arthro.2022.10.040

Vancouver

Lee MS, Nam-Woo Kim D, Moran J, Gillinov SM, Mahatme RJ, Monahan PF, et al. Patients Undergoing Primary Hip Arthroscopy Report Favorable Outcomes at Minimum 10 Year Follow‐Up: A Systematic Review. Arthroscopy. 2023;39(2):459-475. doi:10.1016/j.arthro.2022.10.040

BibTeX
@article{Lee2023,
  author = {Lee, Michael S and Nam-Woo Kim, David and Moran, Jay and Gillinov, Stephen M and Mahatme, Ronak J and Monahan, Peter F and Islam, Wasif and Mclaughlin, William M and Grimm, Nathan L and Jimenez, Andrew E},
  title = {Patients Undergoing Primary Hip Arthroscopy Report Favorable Outcomes at Minimum 10 Year Follow‐Up: A Systematic Review},
  journal = {Arthroscopy},
  year = {2023},
  volume = {39},
  number = {2},
  pages = {459--475},
  doi = {10.1016/j.arthro.2022.10.040}
}
Kostenlos starten →